Effects of peroxisome proliferator-actvated receptors-γamma ligands on dextran sodium sulphate-induced colitis in rats

Journal of Physiology and Pharmacology

Volumn 62, Issue 3, 2011, Pages 347-356

  Celinski, K ^a   Dworzanski, T ^a   Korolczuk, A ^a   Piasecki, R ^b   Slomka, M ^a   Madro, A ^a   Fornal, R ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Provincial Hospital in Zamo   (Poland)

^c Provincial Hospital in Krosno   (Poland)

Author keywords

Bisphenol A diglycidyl ether; Dextran sodium sulphate; Inflammatory bowel disease; Peroxisome proliferatoractivated receptor ; Rosiglitazone; Ulcerative colitis

Indexed keywords

2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DECAPITATION; DRUG EFFICACY; EDEMA; ENZYME ACTIVATION; HISTOPATHOLOGY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE; TREATMENT RESPONSE; ULCER;

ANIMALS; BEHAVIOR, ANIMAL; CARCINOGENS; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; EPOXY COMPOUNDS; HYPOGLYCEMIC AGENTS; INTESTINAL MUCOSA; INTESTINE, LARGE; LIGANDS; PEROXIDASE; PPAR GAMMA; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 80355146332     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stanislawowski M, Wierzbicki PM, Golab A, et al. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J Physiol Pharmacol 2009; 60(Suppl 4): 71-75.
2. Konturek PC, Brzozowski T, Engel M, et al. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 2009; 60: 41-47.
3. Zwolinska-Wcislo M, Brzozowski T, Budak A, et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol 2009; 60: 107-118.
4. Holma R, Salmenpera P, Virtanen I, Vapaatalo H, Korpela R. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. J Physiol Pharmacol 2007; 58: 455-467.
5. Celinski K, Dworzanski T, Korolczuk A, et al. Activated and inactivated PPARs-g modulate experimentally, induced colitis in rats. Med Sci Monit 2011; 17: BR116-BR124.
6. Dworzanski T, Celinski K, Korolczuk A, et al. Influence of the peroxisome proliferators-activated receptor gamma (PPAR-g) agonist, rosiglitazone and antagonist, bisphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats. J Physiol Pharmacol 2010; 61: 683-693.
7. Ricote M, Huang JT, Welch JS, Glass CK. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 1999; 66: 733-739.
8. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferators-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
9. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 2003; 100: 6712-6717.
10. Thieringer R, Fenyk-Melody JE, Le Grand CB, et al. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol 2000; 164: 1046-1054.
11. Shimizu M, Zhao Z, Ishimoto Y, Satsu H. Dietary taurine attenuates dextran sulfate sodium (DSS)-induced experrimental colitis in mice. Adv Exp Med Biol 2009; 643: 265-271.
12. Brandl K, Rutschmann S, Li X, et al. Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci USA 2009; 106: 3300-3305.
13. Reber SO, Obermeier F, Straub RH, Veenema AH, Neumann ID. Aggravation of DSS-induced colitis after chronic subordinate colony(CSC) housing is partially mediated by adrenal mechanisms. Stress 2008; 11: 225-234.
14. Sanchez-Hidalgo M, Martin AR, Villegas I, Alarcon de la Lastra C. Rosiglitazone, a PPAR-g ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol 2007; 562: 247-258.
15. Wright H, Clish C, Mikami T, et al. A Synthetic antagonist for the peroxisome proliferator-activated receptor g inhibits adipocyte differentiation. J Biol Chem 2000; 275: 1873-1877.
16. Velde A, Marleen I, Verstege M, Hommes D. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006; 12: 995-999.
17. Celinski K, Dworzanski T, Korolczuk A, Slomka M, Radej S, Piasecki R. Porownanie roznych modeli eksperymentalnego zapalenia jelita grubego majacych zastosowanie w badaniach nowych terapii nieswoistych chorob zapalnych jelit. Gastrologia Polska 2010; 17: 195-201.
18. Dworzanski T. Wplyw agonisty (rosiglitazon) i antagonisty (Badge) receptora PPAR-g na przebieg eksperymentalnego zapalenia jelita grubego szczurow. Rozprawa doktorska. Lublin, Poland, Uniwersytet Medyczny, 2010.
19. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Gastroenterology 2004; 126: 520-528.
20. Saubermann LJ, Nakajima A, Wada K, et al. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 2002; 8: 330-339.
21. Takaki K, Mitsuyama K, Tsuruta O, Toyonaga A, Sata M. Attenuation of experimental colonic injury by thiazolidinedione agents. Inflamm Res 2006; 55: 10-15.
22. Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J. The PPAR-gamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J Clin Immunol 2007; 27: 275-283.
23. Shan YM, Morimura K, Gonzalez FJ. Expression of peroxisome proliferator-activated receptor-g in macrophage suppresses experimental induced colitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G657-G666.
24. Schaefer KL, Denevich S, Ma C, et al. Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. Inflamm Bowel Dis 2005; 11: 244-252.
25. Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptorgamma, reduces acute inflammation. Eur J Pharmacol 2004; 483: 79-93.
26. Naito Y, Takagi T, Uchiyama K, et al. Reduced intestinal inflamation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med 2004; 14: 191-196.
27. Yamamoto K, Ninomiya Y, Iseki M, et al. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor c agonist alleviates the symptoms of DSS-induced colitis. Biochem Biophys Res Commun 2008; 367: 566-572.
28. Kim MG, Yang HN, Kim HW, Jo SK, Cho WY, Kim HK. Il-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity. J Korean Med Sci 2010; 25: 557-563.
29. Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, Straus DS. The peroxisome proliferator-activated receptor g ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin-10 deficiency. Inflamm Bowel Dis 2005; 11: 231-243.
30. Shimizu M, Zhao Z, Ishimoto Y, Satsu H. Dietary taurine attenuates dextran sulfate sodium (DSS)-induced experimental colitis in mice. Adv Exp Med Biol 2009; 643: 265-271.
31. Harold M, Wright HM, Clish CB, et al. A synthetic antagonist for the peroxisome proliferator-activated receptor g inhibits adipocyte differentiation. J Biol Chem 2000; 275: 1873-1877.
32. Cuzzocrea S, Di Paola R, Mazzon E, et al. Role of endogenous ligands for the peroxisome proliferatrs activated receptors alpha (PPAR-a) in the development of inflammatory bowel disease in mice. Lab Invest 2004; 84: 1643-1654.
33. Adachi M, Kurotani R, Morimura K, et al. Peroxisome proliferators activated receptor gamma in colonic epithelial cells protect against experimental inflammatory bowel disease. Gut 2006; 55: 1104-1113.